Avalo Therapeutics AVTX
NASDAQ AVTX
$8.51 +1.35 (+18.78%)
As of: Nov 11, 2026 · 3:59 PM EST

Avalo Therapeutics (AVTX) Operating Expenses (2014 - 2026)

Updated

Avalo Therapeutics (AVTX) reported Operating Expenses of $31.52 million for Q2 2026, up 63.2% from $19.32 million a year earlier and up 50.8% from the prior quarter.

Analysis

Avalo Therapeutics (AVTX) Operating Expenses (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Avalo Therapeutics' Operating Expenses came in at $91.42 million, up 50.9% year-over-year; for FY2025, it was $72.98 million, up 5.8% from FY2024.

  • Operating Expenses has a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $68.95 million in FY2024 (+135.5%), $29.28 million in FY2023 (-47.2%), $55.49 million in FY2022 (-36.6%) and $87.53 million in FY2021 (+10.0%).
  • The Q2 2026 figure ranks as the highest quarterly Operating Expenses since Q1 2024.
  • Year over year, Operating Expenses has now increased in each of the last five quarters, with growth averaging 67.3% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q1 2024 (growth of 253.6%); the low point was Q3 2023 (a decline of 63.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $20.9 million (Q1 2026), $19.8 million (Q4 2025) and $19.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 15.99 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 11.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 11.14 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.53 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.00 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 6.66 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.84 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 7.09 Bn
10 Avalo Therapeutics 386.09 Mn -587.48 Mn - 23.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23.40 Mn
Jun 30, 2026 31.52 Mn
Mar 31, 2026 20.90 Mn
Dec 31, 2025 19.80 Mn
Sep 30, 2025 19.20 Mn
Jun 30, 2025 19.32 Mn
Mar 31, 2025 14.67 Mn
Dec 31, 2024 13.50 Mn
Sep 30, 2024 13.11 Mn
Jun 30, 2024 9.58 Mn
Mar 31, 2024 32.77 Mn
Dec 31, 2023 8.23 Mn
Sep 30, 2023 3.99 Mn
Jun 30, 2023 7.79 Mn
Mar 31, 2023 9.27 Mn
Dec 31, 2022 9.75 Mn
Sep 30, 2022 10.85 Mn
Jun 30, 2022 12.86 Mn
Mar 31, 2022 22.03 Mn
Dec 31, 2021 18.18 Mn
API Access

Avalo Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=AVTX&period=max&api_key=YOUR_API_KEY